Medicinal cough syrups now require a doctor’s prescription for purchase, following a government notification issued on Tuesday, June 16, 2026. The Ministry of Health and Family Welfare amended the Drugs Rules, 1945—which govern the Drugs and Cosmetics Act, 1940—to remove cough syrups from the list of products exempt from prescription requirements. This change prohibits all over-the-counter sales of such syrups nationwide.
The recent regulatory change follows a public consultation period that began in December 2025, during which the government invited stakeholders and the public to submit objections and suggestions regarding the proposed amendment.
Context behind the regulatory change
The government’s decision follows a series of international and domestic health crises linked to contaminated cough syrups. Since 2022, cough syrups exported from India have been linked to the deaths of more than 140 children across Central Asia and Africa.
Domestically, the urgency for tighter controls intensified after at least 24 children died in Madhya Pradesh last September. Investigations into those fatalities identified that the products had been adulterated with industrial solvents, prompting the Ministry to revise the existing exemptions under the Drugs Rules.
By narrowing the scope of the Drugs and Cosmetics Act, the government is shifting the burden of safety from the consumer to the medical professional. While this limits immediate access for minor ailments, it represents a significant move to mitigate the risks of unregulated solvent contamination that have led to high-profile pediatric fatalities.
What remains available over the counter
Despite the new restrictions on liquid syrups, not all cough-related medications are affected. The government’s notification specifically targets the word “syrups” for removal from the exemption list.
Consequently, other forms of cough relief, including lozenges, pills, and tablets, remain available for purchase without a prescription. These items continue to fall under the previous exemptions established by the Drugs Rules, 1945.
Potential implications for consumers
The shift to a prescription-only model for syrups may lead to increased traffic at primary care clinics as patients seek formal authorization for common cold treatments. Analysts expect that pharmacies will likely implement stricter verification processes for all liquid cough medications to ensure compliance with the updated Drugs Rules.
Furthermore, manufacturers may face increased scrutiny regarding their supply chain and product purity as the government enforces these stricter regulatory standards. It is possible that the industry will see a transition toward the production of alternative delivery methods, such as lozenges, which remain exempt from the new prescription mandate.
Frequently Asked Questions
Are all cough medicines now prescription-only?
No. The new rule applies specifically to “syrups.” Cough lozenges, pills, and tablets remain available over the counter.
What prompted this change in the Drugs Rules?
The amendment follows multiple fatalities linked to syrups adulterated with industrial solvents, including the deaths of 24 children in Madhya Pradesh and over 140 children in Africa and Central Asia since 2022.
When did the government first propose this change?
The government issued a draft notification regarding these changes in December 2025, allowing time for public and stakeholder feedback before the final rule was established on June 16, 2026.
How will these tighter regulations affect your ability to manage common seasonal illnesses at home?
